Applied DNA Sciences Faces Delisting Concerns

Ticker: BNBX · Form: 8-K · Filed: Jun 6, 2025 · CIK: 744452

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

Related Tickers: APDN

TL;DR

APDN might get delisted - stock could be in trouble.

AI Summary

Applied DNA Sciences, Inc. filed an 8-K on June 6, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the date of the earliest event reported as May 30, 2025. The company, incorporated in Delaware, is based at 50 Health Sciences Drive, Stony Brook, NY.

Why It Matters

This filing indicates potential issues with Applied DNA Sciences' continued listing on an exchange, which could significantly impact its stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.

Key Players & Entities

FAQ

What specific listing rule or standard has Applied DNA Sciences failed to satisfy?

The filing does not specify the exact rule or standard that Applied DNA Sciences has failed to satisfy, only that it is a notice of delisting or failure to meet a continued listing requirement.

What is the earliest event date reported in this 8-K filing?

The earliest event date reported in this 8-K filing is May 30, 2025.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on June 6, 2025.

What is the company's primary business address?

The company's primary business address is 50 Health Sciences Drive, Stony Brook, New York 11790.

What is the Commission File Number for Applied DNA Sciences, Inc.?

The Commission File Number for Applied DNA Sciences, Inc. is 001-36745.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing